ALPS ADVISORS INC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$1,003,000
+28.9%
278,504
-4.1%
0.01%
+33.3%
Q2 2019$778,000
-21.5%
290,360
-13.3%
0.01%
-14.3%
Q1 2019$991,000
+94.7%
334,810
+4.5%
0.01%
+75.0%
Q4 2018$509,000
-43.6%
320,350
+30.6%
0.00%
-33.3%
Q3 2018$903,000
+59.0%
245,245
+22.2%
0.01%
+50.0%
Q2 2018$568,000
-17.2%
200,765
+8.5%
0.00%
-20.0%
Q1 2018$686,000
+55.9%
184,968
+21.1%
0.01%
+66.7%
Q4 2017$440,000
-27.3%
152,763
+13.4%
0.00%
-25.0%
Q3 2017$605,000
+6.9%
134,689
+9.1%
0.00%0.0%
Q2 2017$566,000
+14.3%
123,412
+5.0%
0.00%
+33.3%
Q1 2017$495,000
-8.7%
117,588
-10.5%
0.00%
-25.0%
Q4 2016$542,000
-61.6%
131,351
-24.6%
0.00%
-66.7%
Q3 2016$1,411,000
-5.7%
174,246
-9.2%
0.01%
-7.7%
Q2 2016$1,497,000
+26.2%
191,953
+24.9%
0.01%
+8.3%
Q1 2016$1,186,000
-38.9%
153,668
-14.6%
0.01%
-36.8%
Q4 2015$1,941,000
-84.7%
179,877
-2.2%
0.02%
+46.2%
Q3 2015$12,715,000
+1129.7%
184,008
+57.7%
0.01%
+44.4%
Q2 2015$1,034,000
+87.7%
116,661
+108.9%
0.01%
+80.0%
Q1 2015$551,00055,8500.01%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$57,396,0007.04%
HealthInvest Partners AB 497,807$2,096,0003.21%
BVF INC/IL 3,285,400$13,832,0002.35%
EMORY UNIVERSITY 486,438$2,048,0001.93%
Marcus Capital, LLC 69,400$1,751,0001.63%
DAFNA Capital Management LLC 196,500$827,0000.70%
Orbimed Advisors 13,107,200$55,181,0000.62%
Rock Springs Capital Management LP 1,500,000$6,315,0000.36%
Spark Investment Management LLC 710,100$2,989,0000.19%
TURNER INVESTMENTS LLC 65,420$275,0000.18%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders